{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:47:25Z","timestamp":1792183645133,"version":"4.4.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    Diarrheal diseases are one of the major causes of mortality among children under five years old and intestinal pathogenic\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    (InPEC) plays a role as one of the large causative groups of these infections worldwide. InPECs contribute significantly to the burden of intestinal diseases, which are a critical issue in low- and middle-income countries (Asia, Africa and Latin America). Intestinal pathotypes such as enteropathogenic\n                    <jats:italic>E. coli<\/jats:italic>\n                    (EPEC) and enterotoxigenic\n                    <jats:italic>E. coli<\/jats:italic>\n                    (ETEC) are mainly endemic in developing countries, while ETEC strains are the major cause of diarrhea in travelers to these countries. On the other hand, enterohemorrhagic\n                    <jats:italic>E. coli<\/jats:italic>\n                    (EHEC) are the cause of large outbreaks around the world, mainly affecting developed countries and responsible for not only diarrheal disease but also severe clinical complications like hemorrhagic colitis and hemolytic uremic syndrome (HUS). Overall, the emergence of antibiotic resistant strains, the annual cost increase in the health care system, the high incidence of traveler diarrhea and the increased number of HUS episodes have raised the need for effective preventive treatments. Although the use of antibiotics is still important in treating such infections, non-antibiotic strategies are either a crucial option to limit the increase in antibiotic resistant strains or absolutely necessary for diseases such as those caused by EHEC infections, for which antibiotic therapies are not recommended. Among non-antibiotic therapies, vaccine development is a strategy of choice but, to date, there is no effective licensed vaccine against InPEC infections. For several years, there has been a sustained effort to identify efficacious vaccine candidates able to reduce the burden of diarrheal disease. The aim of this review is to summarize recent milestones and insights in vaccine development against InPECs.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2018.00440","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:18:43Z","timestamp":1521505123000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":99,"title":["Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development"],"prefix":"10.3389","volume":"9","author":[{"given":"Maricarmen","family":"Rojas-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micka\u00ebl","family":"Desvaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1086\/499821","article-title":"Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children","volume":"193","author":"Ahmed","year":"2006","journal-title":"J. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1742-4682-6-28","article-title":"In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications","volume":"6","author":"Amani","year":"2009","journal-title":"Theor. Biol. Med. Model."},{"key":"B3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.plantsci.2011.01.004","article-title":"Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice","volume":"180","author":"Amani","year":"2011","journal-title":"Plant Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1016\/j.vaccine.2010.07.061","article-title":"Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157: H7","volume":"28","author":"Amani","year":"2010","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1128\/CVI.00328-08","article-title":"A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model","volume":"16","author":"Bentancor","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1128\/AAC.01661-08","article-title":"Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers","volume":"53","author":"Bitzan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cimid.2008.10.002","article-title":"Immune response against adhesins of enteroaggregative Escherichia coli immunized by three different vaccination strategies (DNA\/DNA, Protein\/Protein, and DNA\/Protein) in mice","volume":"33","author":"Bouzari","year":"2010","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00203-011-0725-6","article-title":"Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC)","volume":"193","author":"Brzuszkiewicz","year":"2011","journal-title":"Arch. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fimmu.2017.00477","article-title":"Immunogenic domains and secondary structure of Escherichia coli recombinant secreted protein Escherichia coli-secreted protein, B","volume":"8","author":"Caetano","year":"2017","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1139\/W10-025","article-title":"Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response","volume":"56","author":"Cai","year":"2010","journal-title":"Can. J. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.vaccine.2010.11.035","article-title":"Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection","volume":"29","author":"Cai","year":"2011","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"17479","DOI":"10.1038\/srep17479","article-title":"Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7","volume":"5","author":"Cai","year":"2015","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1128\/IAI.01024-10","article-title":"Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model","volume":"79","author":"Calderon Toledo","year":"2011","journal-title":"Infect. Immun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1016\/j.vaccine.2008.07.027","article-title":"Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2\/6 agonist MALP-2 as adjuvant","volume":"26","author":"Cataldi","year":"2008","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1128\/CVI.00617-15","article-title":"Characterization of mucosal immune responses to enterotoxigenic Escherichia coli vaccine antigens in a human challenge model: response profiles after primary infection and homologous rechallenge with strain H10407","volume":"23","author":"Chakraborty","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s12275-009-0116-8","article-title":"Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: implications for the vaccine development","volume":"47","author":"Cheng","year":"2009","journal-title":"J. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fmicb.2011.00090","article-title":"The evolution of virulence in non-o157 shiga toxin-producing Escherichia coli","volume":"2","author":"Coombes","year":"2011","journal-title":"Front. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrmicro2265","article-title":"Molecular mechanisms of Escherichia coli pathogenicity","volume":"8","author":"Croxen","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"B19","volume-title":"Preliminary Incidence and Trends of Infection with Pathogens Transmitted Commonly through Food \u2014 Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006\u20132014.","author":"Crim","year":"2015"},{"key":"B20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1128\/CMR.00022-13","article-title":"Recent advances in understanding enteric pathogenic Escherichia coli","volume":"26","author":"Croxen","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/gut.2006.112805","article-title":"Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation","volume":"56","author":"Daley","year":"2007","journal-title":"Gut"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1128\/CVI.00364-12","article-title":"The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease","volume":"19","author":"Darsley","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1751-7915.2011.00276.x","article-title":"Vaccines for the future: learning from human immunology","volume":"5","author":"De Gregorio","year":"2012","journal-title":"Microb. Biotechnol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0264-410X(02)00525-X","article-title":"Coproantibodies to the enteropathogenic Escherichia coli vaccine candidates BfpA and EspB in breastfed and artificially fed children","volume":"21","author":"de Souza Campos Fernandes","year":"2003","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/INF.0b013e318293306c","article-title":"Detection of secretory immunoglobulin A in human colostrum as mucosal immune response against proteins of the Type III secretion system of Salmonella, Shigella and enteropathogenic Escherichia coli","volume":"32","author":"Durand","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-319-45092-6_7","article-title":"Escherichia coli in Animals","volume-title":"Escherichia coli in the Americas","author":"Etcheverr\u00eda","year":"2016"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e00566","DOI":"10.1128\/CVI.00566-16","article-title":"Recent progress in the prevention of serogroup b meningococcal disease","volume":"24","author":"Feavers","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.diagmicrobio.2015.07.016","article-title":"Enteropathogenic and enteroaggregative E. coli in stools of children with acute gastroenteritis in Davidson County, Tennessee","volume":"83","author":"Foster","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1106483","article-title":"Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany","volume":"365","author":"Frank","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(08)60839-9","article-title":"Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial","volume":"371","author":"Frech","year":"2008","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.vaccine.2008.02.070","article-title":"Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch","volume":"26","author":"Frerichs","year":"2008","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1128\/CVI.00473-12","article-title":"Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice","volume":"19","author":"Fujii","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"B33","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1128\/IAI.67.12.6409-6417.1999","article-title":"Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin","volume":"67","author":"Gansheroff","year":"1999","journal-title":"Infect. Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1016\/j.vaccine.2011.06.106","article-title":"Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice","volume":"29","author":"Gao","year":"2011","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.vaccine.2009.01.115","article-title":"Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection","volume":"27","author":"Gao","year":"2009","journal-title":"Vaccine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1128\/IAI.01437-13","article-title":"Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7","volume":"82","author":"Garc\u00eda-Angulo","year":"2014","journal-title":"Infect. Immun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1128\/IAI.73.5.2573-2585.2005","article-title":"Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation","volume":"73","author":"Garmendia","year":"2005","journal-title":"Infect. Immun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1741-7015-10-12","article-title":"Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS)","volume":"10","author":"Goldwater","year":"2012","journal-title":"BMC Med."},{"key":"B40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-319-45092-6_4","article-title":"Atypical Enteropathogenic Escherichia coli","volume-title":"Escherichia coli in the Americas","author":"Gomes","year":"2016"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1016\/j.vaccine.2011.07.069","article-title":"Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice","volume":"29","author":"Gu","year":"2011","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1428","DOI":"10.1371\/journal.pntd.0001428","article-title":"Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates","volume":"5","author":"Harris","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1128\/CVI.05194-11","article-title":"Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines","volume":"18","author":"Harro","year":"","journal-title":"Clin. Vaccine Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1128\/CVI.05342-11","article-title":"A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults","volume":"18","author":"Harro","year":"","journal-title":"Clin. Vaccine Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1574-6968.2009.01664.x","article-title":"An overview of atypical enteropathogenic Escherichia coli","volume":"297","author":"Hernandes","year":"2009","journal-title":"FEMS Microbiol. Lett."},{"key":"B46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1462-5822.2007.01054.x","article-title":"The localized adherence pattern of an atypical enteropathogenic Escherichia coli is mediated by intimin omicron and unexpectedly promotes HeLa cell invasion","volume":"10","author":"Hernandes","year":"2008","journal-title":"Cell. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.vaccine.2013.03.027","article-title":"Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA\/I, CS3, CS5 and CS6 combined with a hybrid LT\/CT B subunit antigen, administered alone and together with dmLT adjuvant","volume":"31","author":"Holmgren","year":"2013","journal-title":"Vaccine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmi.2015.01.015","article-title":"Enteropathogenic Escherichia coli: foe or innocent bystander?","volume":"21","author":"Hu","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"B49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.chom.2007.09.012","article-title":"The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function","volume":"2","author":"Iizumi","year":"2007","journal-title":"Cell Host Microbe"},{"key":"B50","doi-asserted-by":"publisher","first-page":"15010","DOI":"10.1038\/nmicrobiol.2015.10","article-title":"Evolution of atypical enteropathogenic E. coli by repeated acquisition of LEE pathogenicity island variants","volume":"1","author":"Ingle","year":"2016","journal-title":"Nat. Microbiol."},{"key":"B51","volume-title":"The Global Burden of Disease: Generating Evidence, Guiding Policy","year":"2013"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6167","DOI":"10.1016\/j.vaccine.2011.06.084","article-title":"A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression","volume":"29","author":"Isidean","year":"2011","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrmicro818","article-title":"Pathogenic Escherichia coli","volume":"2","author":"Kaper","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.vetmic.2009.04.011","article-title":"Verocytotoxin-producing Escherichia coli (VTEC)","volume":"140","author":"Karmali","year":"2010","journal-title":"Vet. Microbiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1128\/JCM.41.11.4930-4940.2003","article-title":"Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and\/or serious disease","volume":"41","author":"Karmali","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3201\/eid0605.000503","article-title":"Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response","volume":"6","author":"Kimmitt","year":"2000","journal-title":"Emerging Infect. Dis."},{"key":"B57","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1128\/IAI.67.11.6191-6193.1999","article-title":"Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice","volume":"67","author":"Konadu","year":"1999","journal-title":"Infect. Immun."},{"key":"B58","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1128\/iai.62.11.5048-5054.1994","article-title":"Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines","volume":"62","author":"Konadu","year":"1994","journal-title":"Infect. Immun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1086\/514203","article-title":"Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults","volume":"177","author":"Konadu","year":"1998","journal-title":"J. Infect. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12879-014-0728-4","article-title":"Deconstructing the differences: a comparison of GBD 2010 and CHERG's approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologies","volume":"15","author":"Kovacs","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e9046","DOI":"10.1371\/journal.pone.0009046","article-title":"Designed coiled-coil peptides inhibit the Type III secretion system of enteropathogenic Escherichia coli","volume":"5","author":"Larzabal","year":"2010","journal-title":"PLoS ONE"},{"key":"B63","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3389\/fmicb.2015.00823","article-title":"A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles","volume":"6","author":"Leitner","year":"2015","journal-title":"Front. Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1128\/IAI.02928-14","article-title":"Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo","volume":"83","author":"Lewis","year":"2015","journal-title":"Infect. Immun."},{"key":"B65","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00284-016-1070-4","article-title":"Inhibition of adhesion of enteropathogenic Escherichia coli to HEp-2 cells by binding of a novel peptide to EspB protein","volume":"73","author":"Li","year":"2016","journal-title":"Curr. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5929","DOI":"10.1016\/j.vaccine.2009.07.097","article-title":"Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins","volume":"27","author":"Liu","year":"2009","journal-title":"Vaccine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1128\/IAI.00165-11","article-title":"Heat-labile- and heat-stable-toxoid fusions (LTRG-STaPF) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies","volume":"79","author":"Liu","year":"2011","journal-title":"Infect. Immun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.1073\/pnas.1400473111","article-title":"Vaccines against poverty","volume":"111","author":"MacLennan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1128\/IAI.73.8.4810-4817.2005","article-title":"Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge","volume":"73","author":"Mayr","year":"2005","journal-title":"Infect. Immun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1751-7915.2011.00316.x","article-title":"Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge","volume":"5","author":"Mayr","year":"2012","journal-title":"Microb. Biotechnol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1128\/IAI.74.2.994-1000.2006","article-title":"Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults","volume":"74","author":"McKenzie","year":"2006","journal-title":"Infect. Immun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1016\/j.vaccine.2007.01.043","article-title":"Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study","volume":"25","author":"McKenzie","year":"2007","journal-title":"Vaccine"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1016\/j.vaccine.2008.06.064","article-title":"A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic Escherichia coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC","volume":"26","author":"McKenzie","year":"2008","journal-title":"Vaccine"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.EHEC-0003-2013","article-title":"Enterohemorrhagic Escherichia coli Adhesins","volume":"2","author":"McWilliams","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"B76","doi-asserted-by":"publisher","first-page":"24913","DOI":"10.1038\/srep24913","article-title":"Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)","volume":"6","author":"Mejias","year":"2016","journal-title":"Sci. Rep."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1017\/S095026881400137X","article-title":"Defining pathogenic verocytotoxin-producing Escherichia coli (VTEC) from cases of human infection in the European Union, 2007-2010","volume":"143","author":"Messens","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"B78","doi-asserted-by":"publisher","first-page":"fnw179","DOI":"10.1093\/femsle\/fnw179","article-title":"A secretome view of colonisation factors in Shiga toxin-encoding Escherichia coli (STEC): from enterohaemorrhagic E. coli (EHEC) to related enteropathotypes","volume":"363","author":"Monteiro","year":"2016","journal-title":"FEMS Microbiol. Lett."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1128\/IAI.02030-14","article-title":"Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection","volume":"82","author":"Montero","year":"2014","journal-title":"Infect. Immun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1359-6446(03)02689-8","article-title":"Reverse vaccinology","volume":"8","author":"Mora","year":"2003","journal-title":"Drug Discov. Today"},{"key":"B81","doi-asserted-by":"publisher","first-page":"9072","DOI":"10.1073\/pnas.0915077107","article-title":"Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli","volume":"107","author":"Moriel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e00326","DOI":"10.1128\/mSphere.00326-16","article-title":"A novel protective vaccine antigen from the core Escherichia coli genome","volume":"1","author":"Moriel","year":"2016","journal-title":"mSphere"},{"key":"B83","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.11.1.142","article-title":"Diarrheagenic Escherichia coli","volume":"11","author":"Nataro","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e00010-12","DOI":"10.1128\/mBio.00010-12","article-title":"FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections","volume":"3","author":"Nesta","year":"2012","journal-title":"MBio"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1004124","DOI":"10.1371\/journal.ppat.1004124","article-title":"SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains","volume":"10","author":"Nesta","year":"2014","journal-title":"PLoS Pathog."},{"key":"B86","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3201\/eid0905.020441","article-title":"Human milk secretory antibodies against attaching and effacing Escherichia coli antigens","volume":"9","author":"Noguera-Obenza","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/CVI.00538-10","article-title":"Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G\/L211A), as a safe and effective oral adjuvant","volume":"18","author":"Norton","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.trstmh.2008.03.017","article-title":"New insights into the epidemiology of enteropathogenic Escherichia coli infection","volume":"102","author":"Ochoa","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B89","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/QCO.0b013e32834a8b8b","article-title":"Enteropathogenic Escherichia coli infection in children","volume":"24","author":"Ochoa","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1348-0421.2012.00477.x","article-title":"Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice","volume":"56","author":"Oliveira","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fcimb.2012.00081","article-title":"Shiga toxin in enterohemorrhagic Escherichia coli: regulation and novel anti-virulence strategies","volume":"2","author":"Pacheco","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B92","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/JCM.38.7.2696-2700.2000","article-title":"Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies","volume":"38","author":"Parissi-Crivelli","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijmm.2016.02.005","article-title":"Genetic features of human and bovine Escherichia coli O157:H7 strains isolated in Argentina","volume":"32","author":"Pianciola","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e0142927","DOI":"10.1371\/journal.pone.0142927","article-title":"Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food","volume":"10","author":"Pires","year":"2015","journal-title":"PLoS ONE"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"B96","doi-asserted-by":"publisher","first-page":"12283","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e0149358","DOI":"10.1371\/journal.pone.0149358","article-title":"An evidenced-based scale of disease severity following human challenge with enteroxigenic Escherichia coli","volume":"11","author":"Porter","year":"2016","journal-title":"PLoS ONE"},{"key":"B98","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1006\/prep.2001.1604","article-title":"Expression and purification of the recombinant enteropathogenic Escherichia coli vaccine candidates BfpA and EspB","volume":"25","author":"Quintana Flores","year":"2002","journal-title":"Protein Expr. Purif."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.vaccine.2016.04.056","article-title":"The intranasal vaccination of pregnant dams with Intimin and EspB confers protection in neonatal mice from Escherichia coli (EHEC) O157:H7 infection","volume":"34","author":"Rabinovitz","year":"2016","journal-title":"Vaccine"},{"key":"B100","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fcimb.2015.00104","article-title":"Vaccination with DNA encoding truncated enterohemorrhagic Escherichia coli (EHEC) factor for adherence-1 Gene (efa-1') confers protective immunity to mice infected with E. coli O157:H7","volume":"5","author":"Riquelme-Neira","year":"2015","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B101","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-319-45092-6_5","article-title":"Enterohemorrhagic (Shiga Toxin-Producing) Escherichia coli","volume-title":"Escherichia coli in the Americas","author":"Rivas","year":"2016"},{"key":"B102","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1128\/IAI.00264-10","article-title":"Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins","volume":"78","author":"Roy","year":"2010","journal-title":"Infect. Immun."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/CVI.05217-11","article-title":"Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli","volume":"18","author":"Roy","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.1016\/j.vaccine.2009.05.076","article-title":"Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model","volume":"27","author":"Roy","year":"2009","journal-title":"Vaccine"},{"key":"B105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-45092-6_3","article-title":"Typical Enteropathogenic Escherichia coli","volume-title":"Escherichia coli in the Americas","author":"Scaletsky","year":"2016"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e00186-16","DOI":"10.1128\/CVI.00186-16","article-title":"Bioactive immune components of anti-diarrheagenic enterotoxigenic Escherichia coli hyperimmune bovine colostrum products","volume":"24","author":"Sears","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1586\/14760584.2015.996553","article-title":"Implications of enterotoxigenic Escherichia coli genomics for vaccine development","volume":"14","author":"Sj\u00f6ling","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1128\/IAI.68.6.3689-3695.2000","article-title":"Role of EspB in experimental human enteropathogenic Escherichia coli infection","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect. Immun."},{"key":"B109","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fcimb.2016.00094","article-title":"From in silico protein epitope density prediction to testing Escherichia coli O157:H7 vaccine candidates in a murine model of colonization","volume":"6","author":"Tapia","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0140-6736(05)71144-2","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"B111","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1128\/IAI.66.11.5501-5507.1998","article-title":"The EspB protein of enteropathogenic Escherichia coli is targeted to the cytoplasm of infected HeLa cells","volume":"66","author":"Taylor","year":"1998","journal-title":"Infect. Immun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.1016\/j.vaccine.2010.08.047","article-title":"Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria","volume":"28","author":"Tobias","year":"2010","journal-title":"Vaccine"},{"key":"B113","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.vaccine.2007.12.009","article-title":"Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae","volume":"26","author":"Tobias","year":"2008","journal-title":"Vaccine"},{"key":"B114","doi-asserted-by":"publisher","first-page":"8863","DOI":"10.1016\/j.vaccine.2011.09.096","article-title":"Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice","volume":"29","author":"Tobias","year":"2011","journal-title":"Vaccine"},{"key":"B115","doi-asserted-by":"publisher","first-page":"ftx012","DOI":"10.1093\/femspd\/ftx012","article-title":"Escherichia coli diseases in Latin America-a 'One Health' multidisciplinary approach","volume":"75","author":"Torres","year":"","journal-title":"Pathog. Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jped.2017.05.002","article-title":"Maternal immunity, a wayto confer protection against enteropathogenic Escherichia coli","volume":"93","author":"Torres","year":"","journal-title":"J. Pediatr."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1128\/CVI.05345-11","article-title":"Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B","volume":"18","author":"Turner","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1128\/IAI.69.8.4969-4979.2001","article-title":"Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans","volume":"69","author":"Turner","year":"2001","journal-title":"Infect. Immun."},{"key":"B119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-45092-6_1","article-title":"Enterotoxigenic Escherichia coli","volume-title":"Escherichia coli in the Americas","author":"Vidal","year":"2016"},{"key":"B120","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1348-0421.2011.00316.x","article-title":"B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate","volume":"55","author":"Wan","year":"2011","journal-title":"Microbiol. Immunol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1073\/pnas.0510843103","article-title":"A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2","volume":"103","author":"Wen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B122","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.biochem.75.103004.142545","article-title":"Biosynthesis and assembly of capsular polysaccharides in Escherichia coli","volume":"75","author":"Whitfield","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"B123","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.vetmic.2016.02.001","article-title":"Murine immunization with CS21 pili or LngA major subunit of enterotoxigenic Escherichia coli (ETEC) elicits systemic and mucosal immune responses and inhibits ETEC gut colonization","volume":"202","author":"Zhang","year":"2016","journal-title":"Vet Microbiol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1016\/j.vaccine.2011.02.007","article-title":"Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice","volume":"29","author":"Zhang","year":"2011","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.3389\/fmicb.2025.1679236","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000}}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2018.00440\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T08:44:35Z","timestamp":1755679475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2018.00440\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":124,"alternative-id":["10.3389\/fmicb.2018.00440"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.00440","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]},"article-number":"440"}}